Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator Initiated Eight Week Two Center Open-Label Pilot Study of the Tolerability and Safety of Oral UT-15C (Treprostinil Diethanolamine)SR Tablets in Patients With Critical Limb Ischemia (CLI) and Ischemic Rest Pain

NCT00445159 is registered in ClinicalTrials.gov with Southern Arizona Vascular Institute as lead sponsor.

NCT NCT00445159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00445159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator Initiated Eight Week Two Center Open-Label Pilot Study of the Tolerability and Safety of Oral UT-15C (Treprostinil Diethanolamine)SR Tablets in Patients With Critical Limb Ischemia (CLI) and Ischemic Rest Pain
Lead sponsor
Southern Arizona Vascular Institute
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2006
Completion date
Not reported
Enrollment
20
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia